Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
In this podcast, Santosh L Saraf, MD, discusses the decline of estimated glomerular filtration rate in patients with sickle cell disease as an indicator of kidney disease progression. Dr Saraf presented on...
In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also...
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
To examine the prognostic value of flow cytometry plus PET/CT scanning for detecting minimal residual disease in patients with multiple myeloma, researchers conducted an observational cohort study of 94...
For their study, the researchers aimed to clarify the mechanisms behind racial and ethnic disparities in multiple myeloma disease outcomes by investigating the demographic, clinical, and molecular features...
The MAIA study was a phase 3 trial comparing lenalidomide and dexamethasone alone with daratumumab as an add-on therapy to lenalidomide and dexamethasone in patients with transplant-ineligible newly...
The ANDROMEDA study was a phase 3 trial comparing bortezomib, cyclophosphamide, and dexamethasone therapy with daratumumab as an add-on therapy in patients with light chain amyloidosis.
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
In this podcast, Santosh L Saraf, MD, discusses the decline of estimated glomerular filtration rate in patients with sickle cell disease as an indicator of kidney disease progression. Dr Saraf presented on...
In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also...
